Andrew Forrest
12Patents
3h-index
22Co-inventors
60Inventor score
Filing activity: Feb 22, 1988 → Apr 7, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8236786B2 | Respiratory disease treatment | Human Necessities | 27 | Active |
| US4921839A | Erythromycin a 11,12-carbonate 9-oxime derivatives | Chemistry; Metallurgy | 13 | Expired |
| US6943175B2 | 2-NH-heteroarylimidazoles with antibacterial activity | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7220757B2 | Compositions and methods for topical administration of 2-NH-heteroarylimidazoles | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6320051A | Quinolones used as MRS inhibitors and bactericides | Chemistry; Metallurgy | 2 | Expired |
| US6900345B2 | Pleuromutilin derivatives | Chemistry; Metallurgy | 1 | Expired |
| US7569550B2 | 14 and 15 membered ring compounds | Human Necessities | 0 | Expired |
| US7547679B2 | Ether linked macrolides useful for the treatment of microbial infections | Human Necessities | 0 | Active |
| US9078885B2 | Respiratory disease treatment | Human Necessities | 0 | Active |
| US8815837B2 | Respiratory disease treatment | Human Necessities | 0 | Active |
| US7160907B2 | Pleuromutilin derivatives | Chemistry; Metallurgy | 0 | Expired |
| US7718621B2 | Macrolones—amino substituted quinolones | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.